Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

4

all time

Status Distribution
Active(1)
Completed(3)

Detailed Status

Completed3
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed375%
recruiting125%

Recent Activity

1 active trials
Showing 4 of 4
recruiting

Phenotypic Manifestations of Hereditary ATTR Amyloidosis

NCT07124377
completednot_applicable

EEG Monitoring for PERFormance Anticipation

NCT03233282
completednot_applicable

Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)

NCT03188835
completednot_applicable

Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)

NCT05553184

Clinical Trials (4)

Showing 4 of 4 trials
NCT07124377

Phenotypic Manifestations of Hereditary ATTR Amyloidosis

Recruiting
NCT03233282Not Applicable

EEG Monitoring for PERFormance Anticipation

Completed
NCT03188835Not Applicable

Effects of Fructose/Glucose-rich Diet on Brown Fat in Healthy Subjects (GB7)

Completed
NCT05553184Not Applicable

Activation of Brown Adipose Tissue Thermogenesis in Humans Using Formoterol Fumarate (GB10)

Completed

All 4 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
4